BioCentury
ARTICLE | Company News

Eligix receives CE Mark for Bcell-HDM

February 21, 2001 8:00 AM UTC

BioTransplant (BTRN) said that Eligix (Medford, Mass.) received CE mark authorization for its BCell High Density Microparticle (HDM) cell separation device to treat B cell malignancies that are normal...